SKYE: Skye Bioscience, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 320.20
Enterprise Value ($M) 241.46
Book Value ($M) 78.88
Book Value / Share 2.81
Price / Book 4.06
NCAV ($M) 78.62
NCAV / Share 2.80
Price / NCAV 4.07

Profitability (mra)
Return on Invested Capital (ROIC) -0.45
Return on Assets (ROA) -8.17
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 5.99
Current Ratio 5.99

Balance Sheet (mrq) ($M)
Current Assets 94.57
Assets 94.84
Liabilities 15.95
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -13.52
Net Income -37.64
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -13.95
Cash from Investing 6.60
Cash from Financing 16.44

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
03-13 13D/A 5AM Partners VII, LLC 40.00 4.00
02-08 13G Sphera Funds Management Ltd. 5.39
02-05 13G Altium Capital Management LP 5.40 0.00
08-28 13G Versant Venture Capital III, L.P. 19.70

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-22 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-14 80,226 147,498 54.39
2024-05-13 11,930 8,565 139.29
2024-05-10 12,301 11,251 109.33
2024-05-09 16,177 10,759 150.36

(click for more detail)

Similar Companies
SCYX – SCYNEXIS, Inc. SGMT – Sagimet Biosciences Inc.
SIGA – SIGA Technologies, Inc. SLGL – Sol-Gel Technologies Ltd.
SMMT – Summit Therapeutics Inc.


Financial data and stock pages provided by
Fintel.io